Meet Alfa Cytology at the Cancer R&D 2024, Nov 18-20, 2024. We look forward to connecting with you and providing expert solutions for your cancer drug development projects.
Learn MoreFull-time New York, United States
Since pancreatic cancer (PC) is one of the most lethal malignancies with late clinical presentation, early metastasis, and poor prognosis. To improve the diagnosis and treatment of PC, there is an urgent need to find inexpensive, non-invasive, or minimally invasive biomarkers with high sensitivity and specificity. We are committed to helping our global customers advance their progress in PC biomarker discovery and analysis.
We are currently seeking an experienced and highly skilled scientist to join our analytical science department. In this position, the employee is required to have excellent analytical and technical skills to develop and validate our analytical methodologies for PC biomarker discovery, contributing to our goal of advancing PC research and accelerating biotechnology adoption.
Notably, we do not accept calls from applicants. If you are interested in our jobs and meet the requirements, please fill out and submit the following form.
Alfa Cytology is a preclinical research service provider comprised of scientists, bioinformaticians, oncologists, and so on. Our team works closely and communicates actively to achieve our common goals of helping researchers and professionals understand pancreatic cancer biology, explore new pancreatic cancer therapeutics and protocols, and develop new pancreatic cancer biomarkers.